CoChat

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression

Open access

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Targeting checkpoint inhibitors using monoclonal antibodies results in significantly better outcome of cancer patients compared to conventional chemotherapy. However, the current companion diagnostics to predict response is so far suboptimal, since they base on more or less reliable immunohistochemical approaches. In order to overcome these limitations, we analyzed epigenetic modifications of PDCD1 (PD1), CD274 (PD-L1), and CTLA4 in NSCLC tissues from 39 patients. Results were correlated with transcriptome data. Significant differences in the CpG-methylation patterns between tumor tissues and matched controls were observed for CTLA4 and PDCD1 (PD1) showing a decreased methylation of these genes compared to matched tumor-free tissues from the same patients. Results were confirmed by bisulfide sequencing in an independent validation cohort. Hypomethylation also resulted in increased expression of these genes as shown by transcriptome data. These epigenetic pathways as a hallmark of NSCLC might be useful to generate more precise diagnostic approaches in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13148-017-0354-2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Epigenetic and gene expression analyses of immune checkpoint molecules in human NSCLC and corresponding control tissues. HumanMethylation450k BeadChip data, obtained from 39 tumor tissues and their corresponding controls, identified multiple CpG loci differentially methylated in CTLA4 a and PDCD1 (PD1) b genes (FDR < 0.01, t test). For data validation bisulfite pyrosequencing c of an independent patient cohort (n = 20) was performed, confirming differential methylation of tumor tissues detected previously via HumanMethylation450k BeadChip d at selected loci (CTLA4: cg08460026 and cg26091609, PDCD1 (PD1): cg25798782). Heatmap.2 was utilized for hierarchical cluster analysis and data visualization. Blue bars on top of heatmaps: tumor-free lung tissue, yellow bars: tumor tissue. Transcriptome analyses of 18 patients showed elevated transcript expression of CTLA4 e PDCD1 (PD1) Transcriptome analyses of 18 patients showed elevated transcript expression of CTLA4 e PDCD1 (PD1) f and, to a lesser degree, CD274 (PD-L1) g in the tumor samples. Transcriptome data was analyzed via paired t test of quantile-normalized, relative gene expression values with p ≤ 0.05 (=*) regarded as significant
Fig. 1 Epigenetic and gene expression analyses of immune checkpoint molecules in human NSCLC and corresponding control tissues. HumanMethylation450k BeadChip data, obtained from 39 tumor tissues and their corresponding controls, identified multiple CpG loci differentially methylated in CTLA4 a and PDCD1 (PD1) b genes (FDR < 0.01, t test). For data validation bisulfite pyrosequencing c of an independent patient cohort (n = 20) was performed, confirming differential methylation of tumor tissues detected previously via HumanMethylation450k BeadChip d at selected loci (CTLA4: cg08460026 and cg26091609, PDCD1 (PD1): cg25798782). Heatmap.2 was utilized for hierarchical cluster analysis and data visualization. Blue bars on top of heatmaps: tumor-free lung tissue, yellow bars: tumor tissue. Transcriptome analyses of 18 patients showed elevated transcript expression of CTLA4 e PDCD1 (PD1) Transcriptome analyses of 18 patients showed elevated transcript expression of CTLA4 e PDCD1 (PD1) f and, to a lesser degree, CD274 (PD-L1) g in the tumor samples. Transcriptome data was analyzed via paired t test of quantile-normalized, relative gene expression values with p ≤ 0.05 (=*) regarded as significantCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 73

Metadata

Authors
Marwitz, S., Scheufele, S., Perner, S., Reck, M., Ammerpohl, O., & Goldmann, T.
Affiliations
  • German Center for Lung Research (DE)
  • University of Lübeck (DE)
  • Christian-Albrechts-Universität zu Kiel (DE)
Corresponding author
Goldmann, Torsten
Venue
Clinical Epigenetics
Published
2017-05-11
Volume
9
Issue
1
Pages
51-51
ISSN
  • 1868-7075 (ISSN-L)
  • 1868-7083
OpenAlex
W2613059675
Cited by
68
References
6
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 14 · 2021: 12 · 2020: 12 · 2019: 5 · 2018: 10
FWCI
3.02
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Epigenetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Deutsches Zentrum für Lungenforschung (82DZL001A5)
  • German Ministry for Education and Research (01EY1103)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
non-small cell lung cancer, CTLA-4, PDCD1, PD-L1, immune checkpoint genes, DNA methylation, CpG methylation, gene hypomethylation, gene expression, immune checkpoint inhibitors, companion diagnostics, tumor tissue
MeSH terms
Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Cohort Studies, Up-Regulation, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, CpG Islands, DNA Methylation, Gene Expression Profiling, Epigenesis, Genetic, CTLA-4 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. https://app.cochat.ai/papers/10.1186/s13148-017-0354-2
The paper
Marwitz, S., Scheufele, S., Perner, S., Reck, M., Ammerpohl, O., & Goldmann, T. (2017). Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. Clinical Epigenetics. https://doi.org/10.1186/s13148-017-0354-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.